{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:42:13Z","timestamp":1763059333401,"version":"3.40.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MEXT KAKENHI","award":["JP 16K10001","23K21430"],"award-info":[{"award-number":["JP 16K10001","23K21430"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["23ek0109611h0002"],"award-info":[{"award-number":["23ek0109611h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SHISEIKAI Scientific Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91539-2","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:26:45Z","timestamp":1740558405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urinary prostaglandin D2 and E2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Keiko","family":"Ishigaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Taniguchi-Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minobu","family":"Shichiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Urade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"91539_CR1","first-page":"5","volume":"4","author":"Y Fukuyama","year":"1960","unstructured":"Fukuyama, Y., Kawazura, M. & Hamura, H. A peculiar form of congenital muscular dystrophy. Report of fifteen cases. Paediatr. Univ. Tokyo. 4, 5\u20138 (1960).","journal-title":"Paediatr. Univ. Tokyo"},{"unstructured":"Osawa, M. et al. Fukuyama type congenital muscular dystrophy in Congenital Muscular Dystrophies (eds Fukuyama, Y., Osawa, M. & Saito, K.), 31\u201368 (Elsevier Science, 1997).","key":"91539_CR2"},{"doi-asserted-by":"crossref","unstructured":"Ishigaki, K. Fukuyama congenital muscular dystrophy: clinical aspects in Translational Research in Muscular Dystrophy (eds Takeda, S., Miyagoe-Suzuki, Y. & Mori-Yoshimura, M.), 1\u201319 (Springer, 2015).","key":"91539_CR3","DOI":"10.1007\/978-4-431-55678-7_1"},{"key":"91539_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.nmd.2016.09.014","volume":"27","author":"T Sato","year":"2017","unstructured":"Sato, T. et al. The gross motor function measure is valid for Fukuyama congenital muscular dystrophy. Neuromuscul. Disord. 27, 45\u201349 (2017).","journal-title":"Neuromuscul. Disord"},{"key":"91539_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.nmd.2018.08.001","volume":"28","author":"K Ishigaki","year":"2018","unstructured":"Ishigaki, K. et al. National registry of patients with Fukuyama congenital muscular dystrophy in Japan. Neuromuscul. Disord. 28, 885\u2013893 (2018).","journal-title":"Neuromuscul. Disord"},{"key":"91539_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/28653","volume":"394","author":"K Kobayashi","year":"1998","unstructured":"Kobayashi, K. et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388\u2013392 (1998).","journal-title":"Nature"},{"key":"91539_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature10456","volume":"478","author":"M Taniguchi-Ikeda","year":"2011","unstructured":"Taniguchi-Ikeda, M. et al. Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478, 127\u2013131 (2011).","journal-title":"Nature"},{"key":"91539_CR8","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","volume":"14","author":"M Kanagawa","year":"2016","unstructured":"Kanagawa, M. et al. Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy. Cell. Rep. 14, 2209\u20132223 (2016).","journal-title":"Cell. Rep."},{"key":"91539_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/cam.22618","volume":"7","author":"J Holmberg","year":"2013","unstructured":"Holmberg, J. & Durbeej, M. Laminin-211 in skeletal muscle function. Cell. Adh Migr. 7, 111\u2013121 (2013).","journal-title":"Cell. Adh Migr."},{"key":"91539_CR10","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.2353\/ajpath.2009.080709","volume":"174","author":"I Mohri","year":"2009","unstructured":"Mohri, I. et al. Inhibition of prostaglandin D synthase suppresses muscular necrosis. Am. J. Pathol. 174, 1735\u20131744 (2009).","journal-title":"Am. J. Pathol."},{"key":"91539_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-002-0567-z","volume":"104","author":"T Okinaga","year":"2002","unstructured":"Okinaga, T. et al. Induction of hematopoietic prostaglandin D synthase in hyalinated necrotic muscle fibers: its implication in grouped necrosis. Acta Neuropathol. 104, 377\u2013384 (2002).","journal-title":"Acta Neuropathol."},{"key":"91539_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.braindev.2018.06.012","volume":"40","author":"E Takeshita","year":"2018","unstructured":"Takeshita, E. et al. Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers. Brain Dev. 40, 918\u2013925 (2018).","journal-title":"Brain Dev."},{"key":"91539_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2013.03.031","volume":"423","author":"T Nakagawa","year":"2013","unstructured":"Nakagawa, T. et al. A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old. Clin. Chim. Acta. 423, 10\u201314 (2013).","journal-title":"Clin. Chim. Acta"},{"key":"91539_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1212\/WNL.41.1.101","volume":"41","author":"MJ Jackson","year":"1991","unstructured":"Jackson, M. J., Brooke, M. H., Kaiser, K. & Edwards, R. H. Creatine kinase and prostaglandin E2 release from isolated Duchenne muscle. Neurology 41, 101\u2013104 (1991).","journal-title":"Neurology"},{"key":"91539_CR15","doi-asserted-by":"publisher","first-page":"177S","DOI":"10.1042\/bst019177s","volume":"19","author":"A McArdle","year":"1991","unstructured":"McArdle, A., Foxley, A., Edwards, R. H. & Jackson, M. J. Prostaglandin metabolism in dystrophin-deficient MDX mouse muscle. Biochem. Soc. Trans. 19, 177S (1991).","journal-title":"Biochem. Soc. Trans."},{"key":"91539_CR16","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1158\/1055-9965.EPI-09-0680","volume":"18","author":"LM Dong","year":"2009","unstructured":"Dong, L. M. et al. Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women\u2019s health study. Cancer Epidemiol. Biomarkers Prev. 18, 3075\u20133078 (2009).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"91539_CR17","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.1038\/s41598-022-23773-x","volume":"12","author":"W Wen","year":"2022","unstructured":"Wen, W. et al. Association of urinary prostaglandin E2 metabolite and mortality among adults. Sci. Rep. 12, 8905 (2022).","journal-title":"Sci. Rep."},{"key":"91539_CR18","doi-asserted-by":"publisher","first-page":"15277","DOI":"10.1074\/jbc.M506431200","volume":"281","author":"K Aritake","year":"2006","unstructured":"Aritake, K. et al. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J. Biol. Chem. 281, 15277\u201315286 (2006).","journal-title":"J. Biol. Chem."},{"unstructured":"Urade, Y. Benzoimidazole compound capable of inhibiting prostaglandin d synthetase, WO\/2007\/007778 (A1) (2007).","key":"91539_CR19"},{"unstructured":"Urade, Y. Piperazine compound capable of inhibiting prostaglandin d synthase, WO\/2010\/104024 (A1) (2010).","key":"91539_CR20"},{"unstructured":"Urade, Y. Orphan drug development for Duchenne muscular dystrophy by protein crystallization in space. IAC-16-B.3.3.6. In Proc. of 67th International Astronautical Congress (IAC) (2016).","key":"91539_CR21"},{"key":"91539_CR22","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/acn3.651","volume":"5","author":"E Takeshita","year":"2018","unstructured":"Takeshita, E. et al. A phase I study of TAS-205 in patients with Duchenne muscular dystrophy. Ann. Clin. Transl Neurol. 5, 1338\u20131349 (2018).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"91539_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/acn3.50978","volume":"7","author":"H Komaki","year":"2020","unstructured":"Komaki, H. et al. Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy. Ann. Clin. Transl Neurol. 7, 181\u2013190 (2020).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"91539_CR24","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/ijms24032167","volume":"24","author":"C Takahashi","year":"2023","unstructured":"Takahashi, C. et al. Impact of the TRPV2 inhibitor on advanced heart failure in patients with muscular dystrophy: exploratory study of biomarkers related to the efficacy of Tranilast. Int. J. Mol. Sci. 24, 2167 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"91539_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.braindev.2018.07.012","volume":"41","author":"K Ishigaki","year":"2019","unstructured":"Ishigaki, K. et al. Renal dysfunction is rare in Fukuyama congenital muscular dystrophy. Brain Dev. 41, 43\u201349 (2019).","journal-title":"Brain Dev."},{"key":"91539_CR26","doi-asserted-by":"publisher","first-page":"24229","DOI":"10.1038\/s41598-021-03781-z","volume":"11","author":"T Murakami","year":"2021","unstructured":"Murakami, T. et al. Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy. Sci. Rep. 11, 24229 (2021).","journal-title":"Sci. Rep."},{"key":"91539_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ana.21006","volume":"60","author":"C Godfrey","year":"2006","unstructured":"Godfrey, C. et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann. Neurol. 60, 603\u2013610 (2006).","journal-title":"Ann. Neurol."},{"key":"91539_CR28","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1021\/cr2002992","volume":"111","author":"WL Smith","year":"2011","unstructured":"Smith, W. L., Urade, Y. & Jakobsson, P. J. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev. 111, 5821\u20135865 (2011).","journal-title":"Chem. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91539-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91539-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91539-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:02:36Z","timestamp":1744664556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91539-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91539"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91539-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Keiko Ishigaki has received research grants from Sarepta Therapeutics, Inc. (clinical trial), Taiho Pharmaceutical Company, Ltd. (clinical trial), and Nippon Shinyaku Co. Ltd. (clinical trial).The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6873"}}